Test of 5- Versus 10-Day Remdesivir Treatment in Immunocompromised Patients With Coronavirus Disease 2019
- PMID: 36346111
- DOI: 10.1093/cid/ciac877
Test of 5- Versus 10-Day Remdesivir Treatment in Immunocompromised Patients With Coronavirus Disease 2019
Conflict of interest statement
Potential conflicts of interest. The author: No reported conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment in
-
Reply to Yan.Clin Infect Dis. 2023 Mar 21;76(6):1155-1156. doi: 10.1093/cid/ciac878. Clin Infect Dis. 2023. PMID: 36346103 No abstract available.